Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Buy
85,764
+4,203
+5% +$13.1K 0.01% 640
2026
Q1
$238K Sell
81,561
-44,363
-35% -$127K 0.01% 651
2025
Q4
$311K Buy
+125,924
New +$300K 0.01% 558

Other funds holding ABEV

Csenge Advisory Group's ABEV Position: Q2 2026 in Review

Csenge Advisory Group increased its Ambev (ABEV) stake by 5.2% in Q2 2026, buying an estimated $13.1K and bringing the position to 85,764 shares worth $269K. The position accounts for 0.01% of the portfolio, ranked #640.

Csenge Advisory Group first reported a position in ABEV in Q4 2025 and has held it in 3 quarters since. The position peaked at $311K in Q4 2025. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Csenge Advisory Group held 85,764 shares of Ambev worth $269K as of Q2 2026.
  • Csenge Advisory Group bought 4,203 Ambev shares in Q2 2026, an estimated $13.1K.
  • Ambev made up 0.01% of Csenge Advisory Group's portfolio in Q2 2026, its #640 holding.
  • Csenge Advisory Group first reported a position in Ambev in Q4 2025 and has held it in 3 quarters since.
  • Csenge Advisory Group's Ambev position peaked at $311K in Q4 2025.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Csenge Advisory Group's 13F filing for Q2 2026, filed 10 Aug 2026.